Cold temperature improves mobility and survival in Drosophila models of autosomal-dominant hereditary spastic paraplegia (AD-HSP) by Baxter, Sally L. et al.
© 2014. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2014) 7, 1005-1012 doi:10.1242/dmm.013987
1005
ABSTRACT
Autosomal-dominant hereditary spastic paraplegia (AD-HSP) is a
crippling neurodegenerative disease for which effective treatment or
cure remains unknown. Victims experience progressive mobility loss
due to degeneration of the longest axons in the spinal cord. Over half
of AD-HSP cases arise from loss-of-function mutations in spastin,
which encodes a microtubule-severing AAA ATPase. In Drosophila
models of AD-HSP, larvae lacking Spastin exhibit abnormal motor
neuron morphology and function, and most die as pupae. Adult
survivors display impaired mobility, reminiscent of the human disease.
Here, we show that rearing pupae or adults at reduced temperature
(18°C), compared with the standard temperature of 24°C, improves
the survival and mobility of adult spastin mutants but leaves wild-type
flies unaffected. Flies expressing human spastin with pathogenic
mutations are similarly rescued. Additionally, larval cooling partially
rescues the larval synaptic phenotype. Cooling thus alleviates known
spastin phenotypes for each developmental stage at which it is
administered and, notably, is effective even in mature adults. We find
further that cold treatment rescues larval synaptic defects in flies with
mutations in Flower (a protein with no known relation to Spastin) and
mobility defects in flies lacking Kat60-L1, another microtubule-
severing protein enriched in the CNS. Together, these data support
the hypothesis that the beneficial effects of cold extend beyond
specific alleviation of Spastin dysfunction, to at least a subset of
cellular and behavioral neuronal defects. Mild hypothermia, a
common neuroprotective technique in clinical treatment of acute
anoxia, might thus hold additional promise as a therapeutic approach
for AD-HSP and, potentially, for other neurodegenerative diseases.
KEY WORDS: Spastin, Hereditary spastic paraplegia, AD-HSP,
Microtubule severing, Cold treatment, Therapeutic hypothermia,
Drosophila disease model
INTRODUCTION
Hereditary spastic paraplegias (HSPs) are a group of
neurodegenerative disorders marked by lower-limb spasticity
(stiffness) and weakness, leading to progressive difficulty walking
(Fink, 2013; http://www.sp-foundation.org/). Supportive treatments
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exist, but are of mixed efficacy and do not restore mobility. The
most common form, pure autosomal dominant HSP (AD-HSP),
accounts for 70-80% of HSP-afflicted families. AD-HSP pathology
is characterized primarily by degeneration of the longest descending
axons of the central nervous system (CNS). These originate from the
upper motor neurons in the cortex and terminate in the lumbar spine,
innervating the α1 motor neurons that control leg movement. The
relative specificity of the affected neuronal population is striking,
but still not understood.
Over 50% of cases of pure AD-HSP are caused by mutations in
spastin (Hazan et al., 1999), which encodes one of a small family of
microtubule-severing proteins – hexameric ATPases that
disassemble microtubules along their length (Roll-Mecak and
McNally, 2010; Sharp and Ross, 2012). Although it is not yet clear
why Spastin is important in neurons, one thought is that its severing
activity shortens microtubules for efficient transport into axons
(Errico et al., 2002; Yu et al., 2008). Other models suggest that
Spastin is required for net microtubule loss (Trotta et al., 2004) or
growth (Sherwood et al., 2004) at motor neuron synapses, axon
guidance (Wood et al., 2006; Butler et al., 2010) and axon transport
(Kasher et al., 2009; Fassier et al., 2013). Most recently, data has
emerged supporting roles for Spastin in membrane regulation,
promoting tubular endoplasmic reticulum (Park et al., 2010) and
endosomal tubule formation (Allison et al., 2013). Much progress
has been made, but Spastin’s relevant functions, regulatory pathways
and the specific mechanisms by which its mutations lead to axonal
degeneration remain unclear.
Drosophila melanogaster is an effective model system for study
of a wide variety of neurodegenerative diseases because of its high
conservation of neuronal gene function with humans, short
generation time, well-characterized features and the availability of
a wide range of genetic and experimental tools (Bilen and Bonini,
2005). In regards to providing a model for AD-HSP, Drosophila
Spastin, like its vertebrate orthologs, severs purified microtubules
and those in Drosophila S2 cells (Roll-Mecak and Vale, 2005).
Knocking down fly Spastin using a RNA-interference (RNAi)
transgene (Trotta et al., 2004) or deletion of the endogenous gene
(Sherwood et al., 2004) both cause synaptic defects at the
Drosophila larval neuromuscular junction (NMJ), supporting a role
for spastin in regulating synaptic morphology and function.
Orthologs of several other HSP causative genes studied in
Drosophila also exhibit progressive neurodegeneration, supporting
the relevance of flies in providing insights into mechanisms
underlying this disease (Wang and O’Kane, 2008; Ozdowski et al.,
2014).
The spastin gene is completely deleted in the spastin5.75
Drosophila model of AD-HSP (Sherwood et al., 2004). Spastin5.75
larvae are homozygous-viable and have no obvious behavioral
defects, but electrophysiological analysis at the NMJ reveals that
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synaptic strength is reduced. Morphological analysis reveals smaller,
more numerous synaptic boutons that are often arranged in bunches
and contain only sparse microtubules. Adult spastin5.75 flies rarely
eclose (emerge from their pupal cases) and those that do have
severely reduced lifespans, neither fly nor jump, walk and climb
only poorly and, even when still, hold their legs unsteadily. These
phenotypes are equivalently rescued by low level, neuron-specific
expression of Drosophila or human wild-type spastin transgenes,
indicating that Spastin is predominantly required in neurons, and
functions similarly in both organisms (Sherwood et al., 2004; Du et
al., 2010).
Surprisingly, spastin5.75 eclosion improves dramatically when
animals are raised at a reduced temperature of 18°C, compared with
the typical rearing temperature of 24-25°C. Maintaining flies at
18°C is a standard fly husbandry technique that slows development
roughly twofold, but is not associated with systematic loss of
phenotype or enhancement of viability and can in fact adversely
affect stock health. Furthermore, although temperature-sensitive
mutations are common, these typically arise from differences in
mutant versus wild-type protein folding, which is impossible in
spastin5.75 animals given that the gene is completely deleted. This
suggests that the cold-rescuing effect is specific to Spastin
dysfunction, and could therefore provide a novel therapeutic
approach to AD-HSP.
To quantify the effects of cooling, we determined eclosion rate,
climb rate and lifespan for spastin null animals reared at 18°C, and
compared them with values for untreated (non-temperature-shifted)
mutant animals raised at 24°C, as well as with control white-
CantonS (WCS) animals raised in parallel conditions. We looked at
whether the temporal parameters for the cold effect made sense in
the context of when spastin is required. We repeated these
experiments using transgenic strains that express human spastin
genes, to address whether hypothermic rescue held true for flies with
partial human spastin function, which are more representative of the
human disease. Finally, we tested the hypothesis that cold
functionally substitutes for Spastin’s severing activity through the
promotion of microtubule disassembly, and discovered instead that
the alleviatory effects of cooling also extend to other mutations
causing synaptic dysfunction. Mild hypothermia is commonly
employed for neuroprotective purposes during treatment of stroke,
cardiac arrest and other ischemic trauma; our data indicate that
cooling might also be beneficial in AD-HSP and other
neurodegenerative contexts.
RESULTS
Pupal stage cold treatment improves spastin mutant
eclosion
Most Drosophila lacking spastin survive into metamorphosis but fail
to emerge from the pupal case. However, spastin5.75 nulls reared at
18°C rather than 24°C were considerably more successful at
reaching adulthood. We quantified this cold-induced alleviation of
pupal lethality and tested for a developmental period(s) during
which it is effective. Cooling could be required throughout
development, or alternatively, be necessary only at a particular stage.
The former would support a broad effect, such as general
metabolism or developmental rate. The latter, if coinciding with
temporal requirements for Spastin, would support a mechanism
relevant to the loss of Spastin function in the nervous system.
White-CantonS (WCS) controls and spastin5.75 mutant
Drosophila were raised in parallel at 24°C (‘untreated’) or moved
to 18°C during either their larval or pupal stage of development,
and differences in eclosion rates determined for each condition
(Fig. 1A,B). Compared with the 86% eclosion rate of WCS flies,
only 18% of homozygous spastin5.75 flies maintained at 24°C
eclosed (Table 1). Cold treatment specifically during the larval
stage resulted in slightly, but not significantly, higher mutant
eclosion (Table 1; Fig. 1B). Only pupal stage cold treatment
produced a significant increase to levels that, although still well
below wild type, were 70% greater than those for untreated
mutants (Fig. 1B). This effect was specific to the spastin mutation,
as cold did not affect WCS eclosion.
Both pupal and adult cold treatment improve adult mobility
We next looked at whether cold also improves the dramatically
weakened mobility of spastin mutant flies, by measuring adult
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TRANSLATIONAL IMPACT
Clinical issue
Autosomal dominant hereditary spastic paraplegia, or AD-HSP, is an
inherited neurodegenerative disease that manifests as early as
toddlerhood, causing progressive loss of mobility. The primary
symptoms, leg spasticity and weakness, arise from localized
degeneration of the longest central nervous system axons. The
identification of several causative genes has made the study of AD-HSP
using model systems eminently feasible, and the fruit fly Drosophila has
been used extensively to explore the underlying pathology. Spastin, the
gene most commonly mutated in AD-HSP, encodes a member of the
microtubule-severing protein family in both humans and flies, and flies
that lack spastin also exhibit compromised mobility. Despite significant
progress since its discovery, a clear understanding of the role of Spastin
in the nervous system is lacking, and there are still no reliable therapies
for AD-HSP. This study explores a fortuitous observation that cold
temperatures alleviate symptoms in Drosophila models of spastin-
mediated AD-HSP, in order to investigate whether cooling could provide
a therapeutic approach to this disease in humans.
Results
The authors test their hypothesis that cold treatment mitigates behavioral
and cellular spastin mutant defects by examining eclosion (emergence
of adult flies from the pupal case), mobility, lifespan and synapse
morphology in mutant and wild-type flies reared in cold conditions during
discrete developmental periods. They find that in spastin null animals, as
well as in mutant flies that model AD-HSP through the expression of
pathogenic human spastin, cooling alleviates the reduced lifespan,
slowed mobility and aberrant synapse morphology caused by spastin
loss. Cold-induced alleviation of phenotypes was most effective during
the developmental periods, when spastin is required, consistent with the
effects being mediated through a mechanism linked with spastin loss.
The effects were not seen in wild-type animals, demonstrating specific
mitigation of mutant phenotypes. The authors further show that cooling
alleviates neuronal defects due to mutations in a related microtubule-
severing protein, Kat-60L1, and in Flower, which regulates synaptic
vesicle endocytosis. These results provide evidence that moderate
hypothermia could be broadly effective in alleviating neurodegenerative
phenotypes.
Implications and future directions
Therapeutic hypothermia is commonly employed in clinical settings to
prevent anoxia-induced neurological damage following stroke and
cardiac arrest, although the mechanisms for its efficacy remain unknown.
This work implicates cooling as a novel therapeutic approach for
neuronal dysfunction in AD-HSP, and potentially in other
neurodegenerative diseases. Future studies should address the effects
of localized cold treatment in vertebrate models of AD-HSP, and utilize
the Drosophila model system to systematically investigate the underlying
molecular mechanisms and spatiotemporal requirements for the
neuroprotective effects of hypothermia. The work also highlights the
finding that neuronal phenotypes are potentially very sensitive to
variations in temperature, which should be taken into account when
















climbing rates (Table 2; Fig. 2A). All mutants that eclosed following
larval stage cold treatment did not climb, dying shortly after
eclosion. However, spastin5.75 flies cold-treated as pupae climbed
46% faster than mutants maintained at 24°C, and when cold-treated
as adults, climbed 85% faster. By contrast, WCS climbing was
unaffected by pupal and adult cold treatment, and also impaired by
larval-stage treatment (Fig. 2A).
Pupal stage cold treatment extends lifespan
Besides compromised mobility, spastin5.75 flies are short-lived
compared with wild type (Sherwood et al., 2004). Whereas WCS
flies at 24°C lived 3-4 weeks on average, mutants survived only 1
week (Fig. 2B,C, Table 3). As in the climb rate experiments, larval
cold treatment was deleterious to mutant fly survival. Adult-stage
cold treatment extended the average lifespan 2.5-fold but this was
not different from WCS flies, which lived 2.3-fold longer when cold-
treated as adults (Fig. 2B,C). However, whereas pupal cold
treatment left WCS flies unaffected, spastin5.75 flies lived twice as
long as untreated mutants (Fig. 2B). The survival curve for pupal
cold-treated spastin5.75 flies (dark blue solid line) showed a clear
right shift of the entire population relative to untreated mutant flies
(red long dashed line; Fig. 2C). Notably, about 10% of treated
mutants had considerably extended lifetimes, which were threefold
longer than untreated mutants and comparable to the maximal
lifespan of control WCS flies.
These measurements indicate that pupal development is an
effective period for cold to enhance eclosion, mobility and lifespan
of adult spastin5.75 mutants, although it has little effect on wild-
type flies. Additionally, cooling significantly improves mobility
even when applied in spastin5.75 adults, when the nervous system
has already matured. Larval cooling, by contrast, exacerbates
spastin mutant phenotypes in adults. Taken together, these data
indicate that cooling-induced rescue of adult phenotypes arises
from the effects of mild hypothermia on the adult nervous system,
which is assembled de novo during pupal stages as part of
metamorphosis.
Pupal stage cold treatment improves eclosion and mobility
of AD-HSP genotype flies
We sought further evidence for the specificity of cold rescue to loss
of Spastin function by performing the previous experiments in a
Drosophila AD-HSP model that recapitulates spastin gene dosage
and allelic severity of the human disease (Du et al., 2010). We used
two fly strains designed to genocopy humans at the spastin locus. In
the first, denoted HWT,HWT, flies lacking endogenous spastin (i.e.
spastin5.75 flies) instead express wild-type human Spastin, encoded
by two copies of a human spastin transgene, in all neurons. The
second genotype, HL44,HR388, mimics the most severe form of
spastin-mediated AD-HSP in humans (Svenson et al., 2004). Instead
of wild-type human spastin, these flies carry one copy each of
transgenes encoding the S44L or K388R human Spastin mutations
in the fly null background. Pan-neuronal HWT,HWT expression
rescues spastin-null phenotypes equally as well as wild-type
Drosophila spastin transgenes, demonstrating functional
conservation between human and fly Spastin. Flies neuronally
expressing HL44,HR388, however, are severely compromised in
eclosion, mobility and survival. Thus, the HWT,HWT flies provided a
genetic control group (because, like WCS, these express wild-type
spastin) and the HL44,HR388 flies modeled severe AD-HSP.
As further evidence of the therapeutic effect of cold, HL44,HR388 flies
cold-treated as pupae eclosed nearly twice as often as those kept at
24°C, whereas HWT,HWT eclosion was unaffected by cold (Fig. 3A;
Table 4). HL44,HR388 flies also climbed 47% and 60% faster,
respectively, if cold-treated as pupae or adults (Fig. 3B, Table 5), but
cold treatment of HWT,HWT at these stages yielded adults that climbed
only half as quickly. Although spastin transgene expression might
have been reduced at 18°C, our previous studies showed that a single
copy of HWT rescues the null mutants as effectively as two copies,
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Fig. 1. Pupal stage cooling increases spastin5.75 eclosion. (A) Schematic of the experimental paradigms and data gathered throughout this study, for
untreated (no cold treatment), larval, pupal, and adult stage cold administration. (B) Eclosion of homozygous spastin5.75 null mutants increases over 70% when
animals are reared at 18°C as pupae rather than exclusively at 24°C (P<0.02). Larval cooling might also have some positive effect, although this did not reach
statistical significance (P>0.30). By contrast, WCS eclosion is unaffected by cold treatment. *P<0.05.
Table 1. Pupal stage cold treatment significantly increases the eclosion rate of spastin5.75 flies
WCS spastin5.75
Treatment stage Eclosion rate (%) n Eclosion rate (%) n
Untreated 86.3±6.3 10 vials, 143 larvae 18.2±3.1 20 vials, 571 larvae
Larval 76.7±6.1 3 vials, 70 larvae 25.9±8.1 6 vials, 70 larvae
Pupal 80.2±6.2 14 vials, 170 larvae 30.8±3.7 26 vials, 578 larvae
Values shown are mean ± s.e.m. Averages that differ significantly (P<0.05) from the non-cold-treated (untreated) condition of the same genotype are
















making it unlikely that temperature-based alterations in expression
could account for the alleviatory effects seen here (Du et al., 2010).
Overall, the parallels between these results and those for spastin5.75
strongly support the specificity of cold alleviation to defects caused
by Spastin dysfunction in the nervous system.
Cooling rescues synapse morphology defects in spastin
larvae
We next looked at whether cooling rescues the cell biology of
neurons affected in spastin mutants. We were unable to address this
issue in adults because the cellular loci of adult defects in spastin
mutants remain unknown. We thus investigated spastin defects at
the larval NMJ, which are well characterized (Sherwood et al.,
2004). Although previous experiments showed that synaptic
transmission in mutants is reduced relative to wild type at both
normal and low temperatures, we examined whether other cellular
defects at this stage could be alleviated by cold. At room
temperature, spastin mutants have a distinctive NMJ morphology,
with greater numbers of smaller synaptic boutons, which are
sometimes arrayed in grape-like ‘bunches’ and contain only sparse
microtubules (Fig. 4A) (Sherwood et al., 2004; Du et al., 2010;
Ozdowski et al., 2011). These bunched terminal arrangements are
not observed at wild-type NMJs, which consist of large, round and
linearly arrayed boutons penetrated by a clear microtubule bundle.
Comparison of synaptic terminals in 18°C- versus 24°C-reared
larvae showed that cooling mitigated the spastin mutant morphology
(Fig. 4A1,A2), both with respect to the total number of boutons per
muscle and the number of terminal boutons (a measure of synaptic
arbor branching). WCS synapse morphology was unaffected.
However, we did not detect a change in stable microtubule
penetration into terminal boutons, measured by the 22C10 antibody
against the Drosophila MAP1b ortholog, Futsch (Fig. 4A3). Larval
cooling thus partially rescues the cellular defects resulting from
spastin loss, mitigating bouton morphology but not stable
microtubule distribution or synaptic function.
Mutants in flower and kat-60L1 are also rescued by cold
treatment
We have shown that cooling elicits effects specifically on spastin
mutant phenotypes in comparison with controls. To help in
understanding whether cold exerts a general rescuing effect on
defective synaptic growth or whether these effects are also specific
to mutations in spastin, we examined animals with mutations in
flower (fwe), a putative Ca2+ channel that regulates synaptic vesicle
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Table 2. Both pupal and adult stage cold treatment increase the
climb rate of spastin5.75 flies
WCS spastin5.75
Treatment stage Climb rate (cm/s) n Climb rate (cm/s) n
Untreated 2.33±0.08 58 0.65±0.09 25
Larval 1.89±0.10 25 0 18
Pupal 2.33±0.06 95 0.95±0.08 85
Adult 2.51±0.18 23 1.20±0.19 17
Values shown are mean ± s.e.m. Averages that differ significantly (P<0.05)
from the non-cold-treated (untreated) condition of the same genotype are
highlighted in bold.
Fig. 2. Pupal or adult-stage cooling increases
mobility and lifespan of spastin5.75 flies.
(A) Spastin5.75 flies cold-treated as pupae or adults
climb faster than untreated mutants kept at 24°C
(P<0.05 or P<6×10−3, respectively). Cold has no effect
on WCS mobility except when administered during the
larval stage, which decreases climb rates by almost
20% (P<3×10−3). Larval cooling is even more
deleterious to mutants, which are unable to climb after
eclosion. (B) Average adult mutant lifespan is also
considerably reduced by larval cooling, but is nearly
doubled by pupal cooling (P<0.05). Average WCS
lifespan is affected only by adult-stage cold treatment,
which affects mutants to a similar degree (P<2×10−3).
(C) Left: Survival curves overlap between untreated
WCS flies (red triangles, long dashed line) and WCS
flies cooled as larvae (light blue circles, short dashed
line) or pupae (dark blue squares, solid line). Adult
stage cooling (green boxes, dotted dashed line) right-
shifts the population as a whole, doubling average
lifespan. Right: The population of cold-treated
spastin5.75 adults is similarly right-shifted relative to
untreated mutants. However, pupal cooling also right-
shifts the spastin5.75 survival curve and extends
maximum lifespan over threefold compared with
untreated mutants. *P<0.05; **P<0.005.
Table 3. Pupal and adult stage cold treatment both increase the
lifespan of spastin5.75 flies
WCS spastin5.75
Treatment stage Lifespan (days) n Lifespan (days) n
Untreated 25.0±1.6 29 7.0±1.4 7
Larval 22.4±1.8 14 0 18
Pupal 25.5±1.4 33 13.9±1.9 18
Adult 57.0±2.1 13 17.2±2.0 6
Values shown are mean ± s.e.m. Averages that differ significantly (P<0.05)

















endocytosis and has no known link to microtubule regulation (Yao
et al., 2009). Similar to spastin mutants, however, fweDB25/DB56 larval
NMJs have smaller and more numerous boutons, often arrayed in
bunches, and are compromised in synaptic transmission. Rearing
fweDB25/DB56 larvae at 18°C significantly reduced synaptic bouton
number and arrangement to resemble wild-type morphologies
(Fig. 4B), suggesting that the effects of cooling are not limited to
mutations in spastin function.
We also examined adult behavioral phenotypes in mutants of a
gene closely related to spastin, kat-60L1. Like Spastin, Kat-60L1
severs microtubules and is required during larval and pupal neuronal
development, although the precise roles of each protein are distinct
(Lee et al., 2009; Stewart et al., 2012). We examined the effect of
cold on adult fly mobility in kat-60L1PBac, a partial loss of function
line that acts as a strong hypomorph, and in kat-60L1BE6, a
transcriptional null (Stewart et al., 2012). Both alleles are
homozygous-viable and survive more successfully than spastin5.75
null mutants, but also climb more slowly than WCS flies. Pupal cold
treatment increased the average climb rates of both mutants over
35% relative to untreated mutant controls (Fig. 4C), to rates
comparable to WCS controls (compare with Table 2).
DISCUSSION
We have demonstrated that cold temperature alleviates reduced
mobility and survival caused by loss of Spastin function in
Drosophila. This is the case for flies lacking endogenous spastin, as
well as those expressing pathogenic human Spastin. Cold treatment
during the pupal stage of development was sufficient to enhance the
eclosion rate, climbing ability and lifespan of spastin mutant adults.
Furthermore, cold administered only after pupal development, to
fully developed adults, also improved mutant mobility. The timing
of these two effective periods is consistent with the idea that cold
alleviates spastin mutant phenotypes by acting on the developing
adult nervous system during pupal metamorphosis, but is also potent
after the nervous system has matured. This is extremely promising
from a clinical viewpoint, suggesting that the therapeutic window in
AD-HSP includes both developing and mature nervous systems.
Although wild-type levels of mobility and survival were not often
achieved, the temperature shift to 18°C conferred considerable
improvement. Some cold-treated flies were able to jump and even
fly briefly, behaviors not observed in untreated mutants. Cooling can
match or exceed the efficacy of rescue by the microtubule
destabilizing drug vinblastine, which has been proposed as a
therapeutic approach for AD-HSP (Orso et al., 2005). Orso and
colleagues showed that vinblastine doubled the ~12% eclosion rate
of spastin5.75 null mutants; in our hands the drug was ineffective for
null and HL44,HR388 eclosion, but improved eclosion by 65% for
HWT,HR388, which is a more common, representative AD-HSP
genotype associated with milder pathogenesis (Du et al., 2010; Fang
Du and N.T.S., unpublished results). In comparison, pupal cooling
of spastin5.75 null mutants increased eclosion by 70%.
Importantly, cooling during the pupal and adult stages did not
affect eclosion or motor behavior in wild-type flies. This suggests
that cooling not only compensates for defects in neuronal function
caused by lack of Spastin (or other mutations), but is also innocuous
to properly functioning neurons. Although cooling administered at
the larval stage was ultimately deleterious to both control and
spastin mutant adults, mutant larval synapses were effectively
restored to wild-type morphologies. This suggests that cold was
beneficial for some spastin-mediated defects at this stage, but also
had nonspecific, toxic effects on a cell population required later, in
adults.
What is the mechanism(s) underlying the rescuing effect of cold?
Our demonstration that cold alleviates not just spastin mutant
phenotypes, but also mutant phenotypes in fwe and kat-60L1,
indicates that that rescuing effects of cold on nervous system
function might be quite broad. All three genes are important in
synapse formation, although kat-60L1 has been shown to act post-
rather than pre-synaptically at larval and pupal stages. Reduced
temperature could thus be generally beneficial to synaptic
dysfunction, perhaps by reducing activity or metabolic load.
Alternatively, fwe, spastin and kat-60L1 might share a common
pathway component(s), as yet undiscovered, that is directly affected
by cold. For example, cold itself is well known to destabilize
microtubules, particularly at temperatures below 20°C (Delphin et
al., 2012), and is often used in experiments to depolymerize
microtubules (Baas et al., 1994; Cottam et al., 2006). Cold could
thus substitute directly for the microtubule-severing function of
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Fig. 3. Pupal stage cooling increases eclosion and
climb rate in ‘AD-HSP’ flies. (A) Nearly 100% more
animals expressing mutant human spastin (genotype
HL44,HR388) eclose if cooled as pupae, compared with
those maintained at 24°C (P<0.03), whereas eclosion of
flies expressing wild-type human spastin (HWT,HWT) is
unaffected by cold. (B) HL44,HR388 flies cold-treated as
pupae or adults climb nearly 50% (P<2×10−3) and 60%
(P<6×10−4) faster, respectively. By contrast, cooling
decreases climb rates of HWT,HWT flies by 50% for both
pupal (P<1×10−4) and adult treatments (P<7×10−4).
*P<0.05; **P<0.005.
Table 4. Pupal stage cold treatment increases the eclosion rate of HL44,HR388 transgenic flies
HWT,HWT HL44,HR388
Treatment stage Eclosion rate (%) n Eclosion rate (%) n
Untreated 35.1±23.2 2 vials, 54 larvae 11.5±5.0 3 vials, 89 larvae
Pupal 34.6±4.2 8 vials, 244 larvae 22.4±3.1 9 vials, 293 larvae
Values shown are mean ± s.e.m. Averages that differ significantly (P<0.05) from the non-cold-treated (untreated) condition of the same genotype are
















Spastin by promoting microtubule destabilization. Cold-mediated
rescue of Kat-60L1 mutants supported this idea; however, we did
not observe obvious differences in stable microtubule distribution at
cold-treated spastin5.75 synapses or in Drosophila S2R+ cells (data
not shown), and fwe mutants, which have not been implicated in
microtubule dysregulation, were also rescued by cooling.
In humans, cooling has been shown to be generally
neuroprotective, and mild or moderate therapeutic hypothermia (e.g.
33-35°C) has long had clinical applications, including reducing
neurological injury in patients following cardiac arrest, traumatic
brain injury, epilepsy and stroke (Hartemink et al., 2004; Yenari and
Han, 2012). Furthermore, Yang and colleagues found that exposure
to even near-freezing temperatures results in minimal
neuropathology in rat and cat neocortex and hippocampus (Yang et
al., 2006). Although commonly administered in situations involving
acute brain injury, the mechanism by which cooling confers
neuroprotection or therapeutic improvement is unknown,
multifactorial and context-dependent (Choi et al., 2012; Yenari and
Han, 2012).
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Table 5. Pupal stage cold treatment increases the climb rate of
HL44,HR388 transgenic flies
HWT,HWT HL44,HR388
Climb rate Climb rate 
Treatment stage (cm/s) n (cm/s) n
Untreated 1.57±0.07 48 0.72±0.06 44
Pupal 0.80±0.05 33 1.06±0.07 23
Adult 0.76±0.23 7 1.15±0.11 20
Values shown are mean ± s.e.m. Averages that differ significantly (P<0.05)
from the non-cold-treated (untreated) condition of the same genotype are
highlighted in bold.
Fig. 4. Cooling rescues synapse morphology in both spastin and flower mutants, as well as climb rates in kat-60L1 mutants. (A1, A2) Synaptic
terminals of spastin5.75 larvae raised at 25°C have smaller, more numerous and bunched (*) boutons, unlike linearly arrayed WCS boutons. Rearing at 18°C
restores mutant synapse morphology towards wild type, as measured by total number of synaptic boutons per muscle (P<0.02 compared with 25°C mutants)
and terminal bouton number, a measure of arbor branching (P<5×10−3). Bunches are not observed in cold-treated larvae (P<0.03). (A3) Cooling does not
rescue the distribution of stable microtubules within synaptic boutons, as seen by the increased number of boutons without Futsch immunostaining in
spastin5.75 mutants, even with cold treatment. (B1) Mutants in flower, which mediates synaptic vesicle endocytosis, also exhibit small, bunched synaptic
boutons at the larval NMJ that are rescued to more wild-type morphologies by cooling. (B2) Both total and terminal bouton numbers are significantly reduced in
fwe larvae reared at 18°C compared with 25°C (P<4×10−7). (C) Pupal stage cooling increases climb rate in flies lacking Kat-60L1, a microtubule-severing
protein related to Spastin. Flies from cold-treated pupae expressing low (kat-60L1PBac) or no kat-60L1 (kat-60L1BE6) climb faster than untreated flies of the















It will be important to characterize the in vivo effects of cold in
mouse models of AD-HSP (Kasher et al., 2009; Fassier et al., 2013).
The specificity of the effect of cold on mutant and not wild-type
animals in our experiments, together with the spatially localized
neurodegeneration in AD-HSP, suggest that moderate hypothermia
could be applied in a highly targeted manner in this disease context,
with minimal negative effects. Future studies should furthermore
elucidate the underlying cellular mechanisms and potentially
broader applications of cold in alleviating neuronal dysfunction in
neurodegeneration. Because Drosophila are ectothermic, with body
temperatures that vary with their environment, they provide a
straightforward system in which the cell biological effects of
temperature change can be studied in vivo. Finally, our data
highlight the potential sensitivity of neuronal phenotypes to
variations in temperature and thus its importance as a consideration
in studies of neuronal function, neurodegeneration and behavior.
MATERIALS AND METHODS
Drosophila strains
Flies were reared on standard cornmeal/agar/molasses medium at either 24-
25°C (untreated) or 18°C (cold treatment). Genetic controls were white-
CantonS (WCS), the CantonS wild-type strain backcrossed to white ten times
(gift of Anne Simon, Western University, Ontario, Canada) (Sherwood et al.,
2004). Homozygous spastin null (spastin5.75/spastin5.75) animals were
obtained by picking non-Tubby larvae from spastin5.75/TM6B stocks.
Transgenic line HL44,HR388 carried one copy each of transgenes encoding
S44L and K388R human Spastin mutations, expressed via the inducible
geneswitch elav-GAL4 driver (Osterwalder et al., 2001), in the spastin5.75
null background. HWT,HWT flies had two copies of wild-type human Spastin
in the same background (Du et al., 2010). Kat-60L1 mutants were generated
as described previously (Stewart et al., 2011). Trans-heterozygous
flowerDB25/DB56 larvae were maintained at 25°C or 18°C after collecting non-
green progeny at ~stage L2, of fweDB25/TM3,Ser,twi-GAL4,UAS-GFP ×
fweDB56/TM3,Ser,twi-GAL4,UAS-GFP adults allowed to lay on yeasted
grape juice plates.
Assessment of cold treatment on behavioral phenotypes
Third-instar larvae of the appropriate genotype were picked with a cotton
swab and placed in a clean vial. Eclosion rate was calculated as the number
of adult flies from each vial divided by the number of larvae originally
placed into that vial. After eclosing, each adult fly was moved to an
individual food vial.
Adult mobility was assessed via a climb rate test: single flies were
transferred to an empty vial, tapped to the bottom, and the rates at which
they climbed up to an 8-cm mark measured. This was repeated three times
per fly and the results averaged. Flies were then transferred back into their
individual food vial and replaced at either 24°C or 18°C depending on
experimental group. All tests were done at 24°C; adults maintained at 18°C
were first equilibrated for 30 minutes at 24°C prior to being transferred to
the empty vial for testing. Mobility was measured using flies aged 0-27
days. The average age of flies tested was not correlated with the average
climb rates.
Adults were transferred to new food vials every 1-2 weeks to maintain
healthy living conditions. Lifespan was the number of days from eclosion
until death.
The Student’s t-test was used to measure statistical significance. Graphs
are presented as percentage changes due to the large differences between
wild-type and spastin mutant controls; raw values (mean ± s.e.m.) and
number (n) of experiments are listed in the tables and figures.
Neuromuscular junction immunohistochemistry
Third-instar WCS and homozygous spastin5.75 or trans-heterozygous
flowerDB25/DB56 larvae were filleted, dissected and immunostained using
standard methods (e.g. Ozdowski et al., 2011). Briefly, larvae were dissected
in room temperature PBS and fixed for 30 minutes in 4% paraformaldehyde,
immunostained at 4°C overnight using the neuronal membrane marker
rabbit anti-HRP (1:100; Jackson ImmunoResearch, PA, 323-005-021) alone
or with mAb 22C10 to label microtubules (mouse anti-Futsch, 1:50;
Developmental Studies Hybridoma Bank, University of Iowa, Iowa City,
IA). Secondary antibodies (Alexa Fluor 488 goat anti-rabbit A-11070 and
Alexa Fluor 568 goat anti-mouse A-11031; 1:400; Life Technologies, Grand
Island, NY) were incubated for 2-3 hours at room temperature. Fillets were
mounted in H-1000 (Vector Laboratories, Burlingame, CA) and z-series
images of muscle 4 synapses from larval segments 2-4 acquired on a Zeiss
LSM 510 inverted confocal microscope using 63× 1.4 N.A. or 100× 1.2
N.A. PlanApo objectives (Oberkochen, Germany).
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